Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Cancer immunotherapy, which suppresses cancer progression by activating the anti-cancer immunity of patients, shows utility in treating multiple types of cancers. Immunogenic cell death (ICD) induced by most clinical treatment modalities plays a critical role in promoting cancer immunotherapy by rel...

Full description

Bibliographic Details
Main Authors:	Yajie Sun, Xiangru Feng, Chao Wan, Jonathan F. Lovell, Honglin Jin, Jianxun Ding
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Asian Journal of Pharmaceutical Sciences
Subjects:	Immunogenic cell death Nanoparticle Nanoformulation Immunotherapy Multimodal cancer therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1818087620303846

Similar Items

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
by: Rongling Zhao, et al.
Published: (2023-02-01)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
by: Yichen Guo, et al.
Published: (2023-08-01)

MnO2 Nanoflowers Induce Immunogenic Cell Death under Nutrient Deprivation: Enabling an Orchestrated Cancer Starvation‐Immunotherapy
by: Yannan Yang, et al.
Published: (2021-02-01)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
by: Zhiqiang Sun, et al.
Published: (2022-11-01)

Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy
by: Haiqin Song, et al.
Published: (2022-07-01)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano-del Valle, et al.
Published: (2019-04-01)

Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma
by: He C, et al.
Published: (2023-10-01)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
by: Brianne Cruickshank, et al.
Published: (2018-04-01)

Nanoscale metal–organic framework-mediated immunogenic cell death boosting tumor immunotherapy
by: Weidong Ni, et al.
Published: (2022-10-01)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
by: Xiaotian He, et al.
Published: (2023-06-01)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
by: Xi Cao, et al.
Published: (2022-10-01)

Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment
by: Wang J, et al.
Published: (2023-12-01)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano Del Valle, et al.
Published: (2019-11-01)

Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review
by: Xiao-Yang Chen, et al.
Published: (2022-03-01)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
by: Songshan Feng, et al.
Published: (2022-09-01)

Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy
by: Jianhua Liu, et al.
Published: (2021-04-01)

Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
by: Liu Zhiye, et al.
Published: (2023-06-01)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
by: Bingqi Dong, et al.
Published: (2023-05-01)

Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy
by: Jean-David Fumet, et al.
Published: (2020-09-01)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
by: Yingshu Cui, et al.
Published: (2023-08-01)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
by: Xue Wang, et al.
Published: (2022-11-01)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
by: Yongwhan Choi, et al.
Published: (2020-11-01)

Silver nanoparticles induce a non-immunogenic tumor cell death
by: Maritza Roxana Garcia Garcia, et al.
Published: (2023-12-01)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
by: Elena Catanzaro, et al.
Published: (2022-06-01)

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
by: Jiayi Ye, et al.
Published: (2022-06-01)

Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
by: Kenny Misael Calvillo-Rodríguez, et al.
Published: (2023-11-01)

Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01)

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
by: Jianhua Zhang, et al.
Published: (2023-07-01)

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
by: Xuhui Bao, et al.
Published: (2022-07-01)

Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives
by: Hamid Aria, et al.
Published: (2023-05-01)

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
by: Yajun Han, et al.
Published: (2022-11-01)

Bibliometric analysis of research on immunogenic cell death in cancer
by: Yan Zhou, et al.
Published: (2022-10-01)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
by: Ting Wang, et al.
Published: (2023-04-01)

Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine
by: Qingwen Liu, et al.
Published: (2023-09-01)

Copper-induced injectable hydrogel with nitric oxide for enhanced immunotherapy by amplifying immunogenic cell death and regulating cancer associated fibroblasts
by: Shuilin Shen, et al.
Published: (2023-05-01)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
by: Xinwen Wang, et al.
Published: (2021-11-01)

Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
by: Jiaxin Zhang, et al.
Published: (2023-08-01)

Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer
by: Zong Sheng Guo, et al.
Published: (2022-06-01)

Immunogenic Cell Death Role in Urothelial Cancer Therapy
by: Reza Yadollahvandmiandoab, et al.
Published: (2022-09-01)